Victory in the Aloha State

After more than a decade of advocacy by Hawaiian patient and provider advocacy organizations, Hawaii Governor Josh Green signed HB 1864 into law on July 9, 2026. This legislation requires state-regulated health insurers to cover standard fertility preservation services for individuals facing iatrogenic infertility, including cancer patients. The new law will cover procedures such as sperm banking and egg and embryo freezing and go into effect for health plans issued or renewed in Hawaii after December 31, 2026.

Due to Hawaii’s Prepaid Health Care Act of 1974 (PHCA) – the nation’s only state employer health coverage mandate that predates federal ERISA law – coverage will reach a broader percentage of Hawaii’s population compared to other state fertility preservation laws. We estimate that more than 700,000 Hawaiians, approximately half of the state’s population, will now have fertility preservation coverage should they ever need it.

The Alliance for Fertility Preservation would like to thank every patient advocate and organization that has been fighting tirelessly for this coverage since the first Hawaii bill was introduced in 2012. We are especially grateful for the Hawaii Society of Clinical Oncology, ASCO, Fertility Institute of Hawaii, Breast Cancer Hawaii, ACS CAN, Blood Cancer United, Susan G. Komen and all of the patient advocates who bravely shared their stories throughout this long journey.

Fertility Preservation Toolkit

Thank you for your interest in our toolkits. Please read our Terms of Use carefully as we include information that applies to all our toolkits.

All toolkits are publicly available for individual use without licensing or royalty fees. Such use of toolkits is “single use,” meaning solely for the User’s research, clinical, educational, or other application. User’s email may be added to an email distribution list to receive scientific and updated information about the toolkit(s).

We encourage use of our toolkits. User agrees not to adapt, alter, amend, abridge, modify, condense, make derivative works, or translate toolkits without prior written permission from the Provider. User agrees not to sell or incorporate toolkits into materials that could be sold without prior written consent from the Provider. To inquire about permissions, please email info@a4fp.org.


Terri L. Woodard, M.D.

Terri Woodard

Dr. Terri L. Woodard is an Associate Professor in the Department of Gynecologic Oncology and Reproductive Medicine and Director of Oncofertility Program at the University of Texas MD Anderson Cancer Center. She also holds a joint appointment in the Division of Reproductive Endocrinology and Infertility at the Baylor College of Medicine. She received her medical degree from the University of Pittsburgh School of Medicine and then completed her residency in Obstetrics and Gynecology at the Case Western Reserve MetroHealth and Cleveland Clinic Foundation Program. She completed her fellowship in Reproductive Endocrinology and Infertility at Wayne State University, where she then stayed on as faculty until moving to Houston, Texas.
Dr. Woodard’s Oncofertility program offers comprehensive fertility and family building services to men and women who have been diagnosed with cancer. Her research interests include tracking oncologic and reproductive outcomes and exploring ways to educate and support women as they make decisions about fertility preservation. Her decision aid, Pathways earned a Hermes Gold Award. She is a recipient of a NCCN Young Investigator Award. She has also served as an educational resource, providing testimony for legislative bills supporting fertility preservation in the state of Texas.